Secondary sale in a leading Nordic biotech company
- 🇩🇰 Nordic Innovators Corporate Finance ApS
Explore Deal Preview
- September 17, 2026
🇳🇴
- Healthcare, Biotech & Pharma
Confidential
Secondary sale in a leading Nordic biotech company
Deal Crux
N/A
Learn More About This Deal:
- EMEA
- 🇳🇴 Norway
- Healthcare, Biotech & Pharma
- Sell
- 2026
Nordic Innovators Corporate Finance acted as financial advisor in connection with a secondary sale of shares in a leading Nordic biotech company.
Member Firm
🇩🇰
Nordic Innovators Corporate Finance ApS
NICF is a Nordic M&A boutique advising founders, boards and management on mid-size transactions and commercial expansion in Europe. We specialise in growth & project financing, as well as M&A and commercial advisory.
Execution-first and discreet, we structure and control the process and negotiate terms to deliver clean, on-time transactions across the European region.
- www.nicf.dk
- info@nicf.dk
Healthcare, Biotech & Pharma
Other Deals in this Sector
Our global partners gain competitive advantages that transform their ability to win and close international deals across 14 core sectors.
🇩🇰 Nordic Innovators Corporate Finance ApS
Other Deals by Member Firm
Advisiom partner firms share deep industry knowledge, with partner led execution on cross-border deals, globally.
“Our partner firms are elite and carefully vetted boutique M&A firms who share our values: integrity, entrepreneurship and excellence.”
Amanda Simmons, Msc
Founder & CEO
2026 Cross-Border M&A Advisory That Delivers Results
- 2026